# The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia

> **NCT00687388** · PHASE4 · WITHDRAWN · sponsor: **Samsung Medical Center**

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** selective alpha 1-blockers
- **DRUG:** celecoxib
- **DRUG:** alpha-blocker and NSAID

## Key facts

- **NCT ID:** NCT00687388
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-05
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** in order to prepare a new clinical trial to evaluate with pathological change
- **Last updated:** 2013-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687388, "The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00687388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*